The cost for removal of part of tumor and nerve of eye in Spain typically ranges from $12,000 to $20,000. Final pricing depends on surgical complexity, required neurosurgical involvement, and the clinic category. In the United States, similar oncology procedures cost around $35,000 on average. Patients can find savings of approximately 54% in Spanish medical centers. Estimates generally include preoperative imaging, anesthesia, the surgery, and standard hospital hospitalization.
Bookimed Expert Insight: Choosing JCI-accredited facilities like Clinica Universidad de Navarra ensures access to top-tier oncology. This hospital was the first JCI-accredited center in Spain and uses AI-driven diagnostics. While specialized pediatric care at SJD Barcelona Children’s Hospital may seem premium, they offer a dedicated Molecular Medicine Laboratory. For complex cases, these advanced diagnostics can prevent unnecessary repeat surgeries. This often leads to better long-term value despite a higher initial quote.
Why choose Spain for removal of part of tumor and nerve of eye?
Access advanced Removal of part of tumor and nerve of eye solutions in trusted clinics .
| Turkey | Austria | Spain | |
| Removal of part of tumor and nerve of eye | from $8,500 | from $22,000 | from $12,000 |
Day 1 - Arrival
Day 2 - Pre-Operation
Day 3 - Surgery
Day 4 - Post-Operation
Week 1 - Rehabilitation
Week 2 - Rehabilitation
Week 4 - Rehabilitation
Week 6 - Rehabilitation
Please note, every patient"s recovery timeline and experience may vary slightly.
Dr. Xavier Centeno Fornies trained at the Mayo Clinic and leads the surgery department at Centro Médico Teknon.
The doctor is a highly skilled neurosurgeon specializing in the treatment of brain tumors. With extensive experience in both surgical and non-surgical approaches, the doctor has contributed significantly to advancements in neuro-oncology. The doctor is recognized for implementing cutting-edge techniques and has published numerous research papers in leading medical journals. The doctor is committed to improving patient outcomes through innovative treatment strategies and is actively involved in clinical trials aimed at developing new therapies for brain tumor patients.